4.2 Article

Plasma Pro-Enkephalin A and Ischemic Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.jstrokecerebrovasdis.2021.106237

Keywords

Pro-enkephalin; Stroke risk; REGARDS; Cohort; Epidemiology; Risk factors

Funding

  1. National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS041588]
  2. National Institute on Aging (NIA), National Institutes of Health, Department of Health and Human Service
  3. National Institute of General Medical Sciences [P20 GM135007]
  4. Cardiovascular Research Institute of Vermont at University of Vermont (Burlington)

Ask authors/readers for more resources

This study examined the association of the opioid neuropeptide pro-enkephalin A (PENK-A) with ischemic stroke. The results showed that higher baseline plasma PENK-A levels were independently associated with future stroke risk, particularly in White men. This association had minimal confounding by established stroke risk factors, suggesting a possible causal role in stroke etiology.
Objectives: The opioid neuropeptide pro-enkephalin A (PENK-A) may be a circulating marker of cardiovascular risk, with prior findings relevant to heart failure, kidney disease, and vascular dementia. Despite these findings, the association of PENK-A with ischemic stroke is unknown, so we examined this association in a prospective cohort study and analyzed differences by race and sex. Materials and Methods: The REasons for Geographic and Racial Differences in Stroke study (REGARDS) is a prospective cohort study of 30,239 Black and White adults. Plasma PENK-A was measured in 473 participants that developed first-time ischemic stroke over 5.9 years and 899 randomly selected participants. Cox models adjusted for demographics and stroke risk factors were used to calculate hazard ratios (HRs) of stroke by baseline PENK-A. Results: PENK-A was higher with increasing age, female sex, White race, lower body mass index, and antihypertensive medication use. Each SD higher increment of PENK-A was associated with an adjusted HR of 1.20 (95% CI 1.01-1.42) for stroke, with minimal confounding by stroke risk factors. Spline plots suggested a U-shaped relationship, particularly in White men, with an adjusted HR 3.88 (95% CI 1.94-7.77) for the 95th versus 50th percentile of PENK-A in White men. Conclusions: Higher baseline plasma PENK-A was independently associated with future stroke risk in REGARDS. This association was most apparent among White men. There was little confounding by established stroke risk factors, suggesting a possible causal role in stroke etiology. Further research is needed to understand the role of endogenous opioids in stroke pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available